BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2874994)

  • 1. New isoxazole derivatives with a potent and selective beta 2-adrenergic activity.
    Chiarino D; Fantucci M; Carenzi A; Della Bella D; Frigeni V; Sala R
    Farmaco Sci; 1986 Jun; 41(6):440-53. PubMed ID: 2874994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broxaterol: pharmacological profile of a unique structural feature.
    Della Bella D
    Respiration; 1989; 55 Suppl 2():10-4. PubMed ID: 2572035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioselective beta-adrenoceptor blocking actions of some 2-methoxyphenylethanolamines in guinea pig tissues.
    Letts LG; Temple DM; Williams LR
    Circ Res; 1980 Jun; 46(6 Pt 2):I51-2. PubMed ID: 6103760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New beta-diketone and 3,5-dimethyl isoxazole derivatives of theophylline as potential bronchodilator agents.
    Akgün H; Balkan A; Erol K; Batu OS
    Arzneimittelforschung; 1998 Jun; 48(6):658-62. PubMed ID: 9689423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivatives related to betaxolol with alpha- and beta-adrenergic activities.
    Leclerc G; Decker N; Schwartz J
    Arzneimittelforschung; 1985; 35(9):1357-67. PubMed ID: 2867769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta-adrenoblocking activity and other pharmacological properties of 2-(3-amino-2-hydroxypropoxy)phenyoxymethyl isoxazole derivatives].
    Iuzhakov SD; Zaĭtseva KA; Dorodnikova EV; Mashkovskiĭ MD
    Farmakol Toksikol; 1985; 48(3):36-40. PubMed ID: 2863169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
    Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
    Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantiomers of 8-(3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydro-3-oxo-2H- (1,4)benzothiazine: racemic resolution, chiral synthesis and biological activity.
    Schiaffella F; Fringuelli R; Cecchetti V; Fravolini A; Angeli P; Marucci G
    Farmaco; 1990 Dec; 45(12):1299-307. PubMed ID: 1982489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and cardioselective beta-adrenergic antagonist activity of quinolyloxypropanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1992; 9(1):69-78. PubMed ID: 1360842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (I).
    Khouili M; Guillaumet G; Coudert G; Pujol MD
    Farmaco; 1996 Mar; 51(3):175-84. PubMed ID: 8688139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Adrenergic blocking action of halonitrophenethanolamines.
    Letts LG; Easson PA; Temple DM; Williams LR; Pasaribu SJ; Lap BV; Lim CH
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):105-13. PubMed ID: 39529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Search for new beta-adrenoblockaders among derivatives of (3-amino-2-hydroxypropoxy) phenoxymethyl isoxazole].
    Iuzhakov SD; Sokolov SD; Vinogradova SM
    Farmakol Toksikol; 1988; 51(4):47-52. PubMed ID: 2903834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
    Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
    J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and beta-adrenergic activity of new completely aliphatic 3-(methyleneaminoxy)propanolamine derivatives.
    Balsamo A; Gentili D; Lapucci A; Macchia M; Martinelli A; Orlandini E; Ferni G; Pinza M
    Farmaco; 1994 Dec; 49(12):759-66. PubMed ID: 7893332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential in vivo and in vitro bronchorelaxant activities of CP-80,633, a selective phosphodiesterase 4 inhibitor.
    Wright KF; Turner CR; Jayasinghe-Beck R; Cohen VL; Cheng JB; Watson JW
    Can J Physiol Pharmacol; 1997 Aug; 75(8):1001-8. PubMed ID: 9360015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and beta-adrenergic antagonist activity of novel (3-cyanodihydropyridyl)propanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1991 Dec; 8(2):157-64. PubMed ID: 1686561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. I: Bronchodilating effect.
    Murai T; Maejima T; Sanai K; Osada E
    Arzneimittelforschung; 1984; 34(11A):1633-40. PubMed ID: 6152156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of the new alpha- and beta-adrenergic antagonist 1-[1-(2-benzodioxanylmethyl)-4-piperidyl]amino-3-(1-naphthoxy)-2- propanol.
    Mauleón D; Antúnez S; Rosell G
    Farmaco; 1989 Nov; 44(11):1109-17. PubMed ID: 2577151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies on beta-adrenolytic potencies of some new phenoxyaminopropanol derivatives and celiprolol.
    Mlynárová R; Racanská E
    Pharmazie; 1997 Mar; 52(3):234-7. PubMed ID: 9109170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.